Biomedicines JCR、Cells、Biomedicines在PTT/mobile01評價與討論，在ptt社群跟網路上大家這樣說
Biomedicines JCR關鍵字相關的推薦文章
Biomedicines JCR在Biomedicines | An Open Access Journal from MDPI的討論與評價
Biomedicines 2022, 10(2), 368; https://doi.org/10.3390/biomedicines10020368 (registering DOI) - 02 Feb 2022. Abstract. Accumulating evidence suggests a ...
Biomedicines JCR在Biomedicines 最新影響指數- 實時趨勢預測& 期刊影響力排名的討論與評價
Academic Accelerator; 2021-2022 影響指數; Biomedicines ... calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR).
Biomedicines JCR在Biomedicines- Impact Score, Overall Ranking, h-index, SJR ...的討論與評價
Biomedicines is a journal covering the technologies/fields/categories related to Biochemistry, Genetics and Molecular Biology (miscellaneous) ( ...
Biomedicines JCR在ptt上的文章推薦目錄
Biomedicines JCR在Biomedicines - Scimago Journal & Country Rank的討論與評價
Biomedicines open access ... Natural Biomedicines Including Marine, Plant, and Animal-Derived Biomedicines; ... CAN WE FIND THIS JOURNAL IN JCR?
Biomedicines JCR在Biomedicine & Pharmacotherapy - Journals | Elsevier的討論與評價
Biomedicine & Pharmacotherapy · The Impact Factor of this journal is 6.529, ranking it 25 out of 275 in Pharmacology & Pharmacy · With this journal indexed in 12 ...
Biomedicines JCR在Biomedicines-期刊论坛，投稿经验-MedSci.cn - 梅斯医学的討論與評價
经验分享：期刊介绍Biomedicines是一本同行评审的在线发表开放获取国际性生物医学期刊，由国际知名出版商MDPI ... 分区情况：JCR分区都是Q1，中科院分区目前还未出来。
Biomedicines JCR在BioMedicine, a Peer-Reviewed, Open Access Journal的討論與評價
BioMedicine, a peer-reviewed, open access quarterly journal, publishes high-quality scientific research in the fields of precision medicine with the goal of ...
Biomedicines JCR在Journal of APPLIED BIOMEDICINE的討論與評價
1.797 – 2-year Impact Factor; 1.684 – 5-year Impact Factor; EISSN 1214-0287 • ISSN 1214-021X; double-blind evaluation of manuscript by ...
Biomedicines JCR在BioMed Research International | Hindawi的討論與評價
BioMed Research International publishes original research articles and review articles covering a wide range of subjects within the biomedical sciences.